Clinical Trials Browser

Endometrial Hyperplasia

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms

Adenosarcoma of the uterus, Sarcoma, Endometrial Stromal, Perivascular Epithelioid Cell Neoplasms

Uterine Cervical Dysplasia

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Locally Advanced Cervical Cancer

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Endometrial Hyperplasia

Fallopian Tube Neoplasms

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

Uterine Cervical Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

Ovarian Neoplasms

Ovarian Neoplasms

Squamous Intraepithelial Lesions

Adenocarcinoma, Uterine Cervical Neoplasms

Turcot syndrome, Endometrial Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

Ovariancancer

Ovarian Neoplasms

Endometrial Neoplasms

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Uterine Cervical Neoplasms

Ovarian Neoplasms, Recurrence

Carcinoma, Ovarian Epithelial

Platinum-resistant Recurrent Ovarian Cancer (PROC)

Ovarian Neoplasms

Ovarian Cancer Recurrent

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Advanced Endometrial Cancer

Uterine Cervical Neoplasms

Ovarian Neoplasms

Cervical Cancer Metastatic

Uterine Cervical Neoplasms, Communicable Diseases, Neoplasms

Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Clinical Trials

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

MITO END-4

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

ART-Hypo

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

BACON

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer

Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer

RIFT-SSA

The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression

Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

IMMUNE-SAVE

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.

A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer

EV-4-EC

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer

TROY

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer

EZHiSWITCH

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer

Topical Curcumin for HPV Related Cervical Disease

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

RODEO